Susan Klaeger
Harvard University
H-index: 23
North America-United States
Top articles of Susan Klaeger
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract A038: Non-canonical MHC class I-associated antigens in pancreatic cancer | Cancer Research | Zackery A Ely Zachary J Kulstad Eva K Verzani Jennifer G Abelin Sudarsana Addepalli | 2024/1/16 |
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer | Nature Cancer | Ines Mota Enrico Patrucco Cristina Mastini Navin R Mahadevan Tran C Thai | 2023/7 |
1408 Non-canonical peptide sources broaden the landscape of targetable antigens in pancreatic cancer | Zackery A Ely Zachary J Kulstad Jennifer G Abelin Eva K Verzani Sudarsana Addepalli | 2023/11/1 | |
Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry | Molecular & Cellular Proteomics | Kshiti Meera Phulphagar Claudia Ctortecka Alvaro Sebastian Vaca Jacome Susan Klaeger Eva K Verzani | 2023/6/1 |
Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies | Frontiers in immunology | Shanye Yin Susan Klaeger Vipheaviny A Chea Isabel P Carulli Suzanna Rachimi | 2023/10/20 |
The peptide woods are lovely, dark and deep: hunting for novel cancer antigens | Daniel Oreper Susan Klaeger Suchit Jhunjhunwala Lélia Delamarre | 2023/5/1 | |
Abstract A013: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma | Cancer Research | David A Braun Derin B Keskin Sachet A Shukla Bradley A McGregor Nicholas R Schindler | 2023/8/15 |
Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation | Blood | Nicoletta Cieri Nidhi Hookeri Kari Stromhaug Liang Li Julia Keating | 2023/11/28 |
Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues | Nature Communications | Jennifer G Abelin Erik J Bergstrom Keith D Rivera Hannah B Taylor Susan Klaeger | 2023/4/3 |
Abstract PR015: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma | Cancer Research | David A Braun Derin B Keskin Sachet A Shukla Bradley A McGregor Nicholas R Schindler | 2023/8/15 |
An Analytic Framework for the Prediction of Gvl Minor Histocompatibility Antigens to Prevent or Treat Post-Transplant Relapse | Blood | Nicoletta Cieri Liang Li Nidhi Hookeri Kari Stromhaug Julia Keating | 2023/11/28 |
Pan-viral ORFs discovery using Massively Parallel Ribosome Profiling | bioRxiv | Shira Weingarten-Gabbay Matthew R Bauer Alexandra C Stanton Susan Klaeger Eva K Verzani | 2023 |
Compositions and methods for treating merkel cell carcinoma (mcc) using hla class i specific epitopes | 2023/8/10 | ||
145 Proteogenomic approaches for exploring the dark immunopeptidome | Kristin Leskoske Hem Gurung Ana Magalhaes Samir Vaidya Daniel Le | 2023/11/1 | |
Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer | Nature biotechnology | Tamara Ouspenskaia Travis Law Karl R Clauser Susan Klaeger Siranush Sarkizova | 2022/2 |
OTUD6B is a dependency in multiple myeloma that drives S-phase entry via MYC activation | Cancer Research | Ria Spallek Carmen Paulmann Oleksandra Karpiuk Jana Zecha Susan Klaeger | 2022/6/15 |
Proteogenomic Analysis of SF3B1mut CLL Reveals Altered Protein Signaling Cascades and Metabolomic Pathways | Blood | Susan Klaeger Eugen Tausch Binyamin A Knisbacher Annie Apffel Karl R Clauser | 2022/11/15 |
Virally mediated mechanisms of HLA class I loss in Merkel cell carcinoma and implications for viral epitope presentation | Journal of Investigative Dermatology | Derin B Keskin Patrick C Lee Susan Klaeger Phuong M Le Keegan Korthauer | 2022 |
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma | Nature | Giacomo Oliveira Kari Stromhaug Nicoletta Cieri J Bryan Iorgulescu Susan Klaeger | 2022/5/19 |
Abstract C014: Broadening the repertoire of PDAC-specific targets for immune-based therapy through high-resolution immunopeptidomics | Cancer Research | Zackery A Ely William A Freed-Pastor Zachary J Kulstad Jennifer G Abelin Eva Verzani | 2022/11/15 |
